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Key points: 
• ATMIN deletion using Vav-Cre causes chronic leukopenia, with fewer B 
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• Long-term hematopoietic stem cells in ATMIN-deficient mice show 
increased cell cycling and are more prone to exhaustion under stress 
  2 
Abstract 
The ATM-interacting protein ATMIN mediates non-canonical ATM signaling in 
response to oxidative and replicative stress conditions. Like ATM, ATMIN can 
function as a tumor suppressor in the hematopoietic system: deletion of Atmin 
under the control of CD19-Cre results in B cell lymphomas in aging mice. ATM 
signaling is essential for lymphopoiesis and hematopoietic stem cell (HSC) 
function; however, little is known about the role of ATMIN in hematopoiesis. 
We thus sought to investigate if the absence of ATMIN would affect primitive 
hematopoietic cells in an ATM-dependent or -independent manner. Apart from 
its role in B cell development, we show that ATMIN has an ATM-independent 
function in the common myeloid progenitors (CMPs) when Atmin is deleted in 
the entire hematopoietic system using Vav-Cre. Despite the lack of lymphoma 
formation, the chronic leukopenia in ATMIN-deficient mice, as a result of high 
levels of apoptosis in B cells and CMPs and induced a compensatory 
mechanism in which HSCs displayed enhanced cycling. Consequently, 
ATMIN-deficient HSCs showed impaired regeneration ability, especially when 
aged with the induction of the DNA oxidative stress response. ATMIN 
therefore has multiple roles in different cell types and its absence results in 
perturbed hematopoiesis, especially during stress conditions and aging. 
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Introduction  
 ATM (ataxia telangiectasia mutated) coordinates cell-cycle checkpoints 
with DNA repair in response to DNA damage1. ATM can be activated by the 
MRN complex (MRE11/RAD50/NBS1) via interaction with NBS12 but can also 
be activated by the ATM interactor ATMIN3. ATMIN has a complementary 
function to NBS1: ATMIN is dispensable for ionizing radiation-induced ATM 
signaling, whereas NBS1 is dispensable for ATM activation following ionizing 
damage or hypotonic stress3,4. 
 ATMIN has been shown to function in conditions of oxidative stress 
and aging5 and also as a transcription factor6. We have previously shown that 
ATMIN-deleted B cells (induced by CD19-Cre) have impaired class switch 
recombination and increased genomic instability, leading to B cell 
lymphomas7. In contrast, mice conditionally deleted of Atmin using Mx1-Cre 
developed B cell lymphopenia8. It is unclear whether the lack of B cell 
lymphoma formation in this mouse model is due to a B cell developmental 
defect or to other deficiencies in primitive hematopoietic cells that prevent the 
accumulation of genetically unstable cells. Since the role of ATMIN in 
hematopoietic stem/progenitor cells is currently unknown, we sought to 
investigate a possible role for ATMIN in primitive hematopoietic cells and 
whether this would be ATM-dependent or -independent.  
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Materials and Methods 
Vav-AtminΔ/Δ mice 
Atminf/f mice (described previously5,7) were crossed with heterozygous Vav-
Cre mice to generate Vav-Atmin∆/∆ mice. Gene deletion efficiency and 
genotyping was determined using a PCR-based assay using primers specific 
for the floxed exon 4, deleted exon 4 and WT Atmin alleles as well as for Vav-
Cre (See Table S1). 
 
Intracellular immunostaining 
 As briefly described9, cells were incubated with antibodies against 
extracellular antigens, then fixed in PBS with 2% methanol-free formaldehyde 
at room temperature (RT) (for Ki-67; BD Biosciences) or at 37°C (for pKap1; 
Bethyl Laboratories and Bim; Cell Signaling) for 10 min. Cells were then 
permeabilized with PBS containing 0.1% Triton-X-100 (Sigma) for 10 min at 
RT, blocked using PBS containing 5% serum for 15 min and incubated with 
primary antibodies at 4°C for 1 hour, followed by appropriate secondary 
antibodies in the same conditions. Cells were resuspended with PBS/2% FBS 
containing DAPI and pulse processing was used to exclude any unstained, 
apoptotic and clumped cells. 
 
Please see Supplementary Information for more detailed Methods. 
 
Results and discussion 
 Vav1 promoter-mediated deletion of Atmin exon 4 generates a null 
allele (Vav-Atmin∆/∆) in the hematopoietic system (Figures S1A and S1B). 
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ATMIN-deficient mice were born healthy and were not anemic but were 
leukopenic at 8-12 weeks (Figure S1C-D). Unlike the CD19-Cre model7, mice 
did not develop lymphoma, and instead numbers of B cells were reduced 
(Figure S2A-F). The numbers of splenic B cells was dramatically reduced 
(Figure S2A, B) and resulted in a complete absence of germinal centers (GC) 
(Figure S2C). B cell apoptosis was increased, and while oxidative stress was 
unaffected there was a pronounced reduction in Dynll1 expression, as 
previously described8 (Figure S2D-F).  The pronounced B cell lymphopenia in 
the Mx-Cre model8 and the Vav-Atmin∆/∆ mice described here are in contrast 
to the CD19-Cre model7, which have normal B cell numbers. The reduction of 
splenic GC B cells may explain the absence of lymphoma development in the 
Mx-Cre model8 and the Vav-Atmin∆/∆ mice. ATMIN-deficient B cells displayed 
a significant increase in the DNA damage response, consistent with an ATM-
dependent competitive function of ATMIN4,7 (Figure S2G-H). Numbers of pre-
B cells in the bone marrow (BM) were also significantly lower (Figure S2I-K). 
These data suggested an early developmental defect that does not allow the 
accumulation of damaged B cells. We thus analyzed the primitive 
hematopoietic cell compartment in more detail.  
 In young ATMIN-deficient mice (8-12 weeks), a ~40% reduction in BM 
cellularity was observed across all cell types, with a reduced frequency of 
common myeloid progenitors (CMPs) (Figure 1A-B). Sub-populations 
upstream of CMPs, particularly LT-HSCs, showed more cells that had exited 
quiescence (Figure 1C), supported by reduced expression of Cdkn1c (p57Kip2) 
in the different primitive cell sub-types and Rbl2 (p130) in LT-HSCs (Figure 
S3A). Increased LT-HSC cycling to compensate for the reduced B cell and 
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CMP compartments in Vav-Atmin∆/∆ mice could potentially affect LT-HSC 
function. Indeed, the regenerative capacity of Vav-Atmin∆/∆ LT-HSCs 16 
weeks post-transplantation was reduced 16-fold compared with control cells, 
affecting all three lineages (Figures 1D and S3B-C). Importantly, ATMIN-
deficient LT-HSCs were mostly unable to regenerate hematopoiesis when re-
transplanted (Figure 1D). Vav-Atmin∆/∆ mice succumbed to multiple doses of 
the myeloid-suppressive agent 5-FU (5-fluorouracil) faster than Atminf/f mice 
(Figure S3D). Despite the apparent lack of oxidative stress and DNA damage 
in young Vav-Atmin∆/∆ cells at steady state (Figure 1E-G), these results 
suggest that stresses induced during regeneration disturbed LT-HSC function.  
 Aged (55-65-week-old) Vav-Atmin∆/∆ mice continued to have reduced 
BM cellularity (Figure 1H) and no incidence of lymphoma. We observed 
similar defects in aged ATMIN-deficient B cells as reported7 (data not shown) 
and also a reduced CMP compartment (Figure 1I). Although numbers of 
short-term (ST)-HSCs and multipotent progenitors (MPPs) were not altered in 
aged ATMIN-deficient mice, the proportion of these sub-populations was 
mildly increased, perhaps because they cycled more in younger but not in 
aged mice (Figure 1H-J). Again, when aged LT-HSCs were transplanted, 
ATMIN-deficient cells were unable to provide long-term reconstitution (Figure 
1K). There were no apparent signs of senescence (such as increased p16Ink4a 
and p19Arf expression) in any of the aged ATMIN-deficient primitive sub-
populations (data not shown) and no increase in ROS production in ATMIN-
deficient LT-HSCs was observed (Figure 1L), unlike Atm-/- mice10,11. However, 
in contrast with young cells, we observed a significant increase in DNA 
oxidation repair gene expression in aged ATMIN-deficient LT-HSCs, and 
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pKap1 expression was upregulated, suggesting increased DNA damage in 
these cells (Figure 1M-N).  
 Next, we went on to investigate the function of ATMIN in the CMP 
compartment. The very modest oxidative stress detected in the myeloid 
progenitors did not seem to play an evident role in reducing this cellular 
fraction in ATMIN-deficient mice (Figure 2A-C). We also observed neither 
increased DNA damage (Figure 2D-E) nor evidence of developmental defects 
(Figure 2F) in Vav-Atmin∆/∆ CMPs compared with control cells. However, a 
significant increase in late apoptosis was detected in Vav-Atmin∆/∆ CMPs 
(Figure 2G) but not in other primitive compartments (not shown) and this was 
accompanied by a ~33-fold decrease in Dynll1 expression (a direct 
transcriptional target of ATMIN6, Figure 2H). Immunofluorescent studies 
revealed significant co-staining of Bim with MitoTracker dye in Vav-Atmin∆/∆ 
cells (Figure 2I-K). This observation is consistent with the decrease in Dynll1 
levels freeing Bim to be translocated into mitochondria, triggering higher 
apoptosis11 in Vav-Atmin∆/∆ CMPs.  
  
 We reveal ATMIN as a novel player with multiple functions in 
hematopoiesis, both ATM-dependent and -independent. Apart from its roles in 
B cell development7,8, we have uncovered an important ATM-independent 
function of ATMIN in the CMP compartment. ATMIN-deficient mice also have 
impaired LT-HSC function during regeneration and aging, most likely due to 
exhaustion from compensating the reduced/damaged lymphoid and myeloid 
compartments over time. It would be interesting to dissect other possible roles 
that ATMIN might have in myeloid development with more specific lineage 
  8 
gene deletion approaches, as myeloid cells can differentiate without passing 
the CMP stage13-15. Interestingly, ATMIN is overexpressed in inv16 acute 
myeloid leukemias (AMLs) compared with normal myeloid cells16, and is 
located on chromosome 16 where rearrangements are common in AML. 
ATMIN may therefore also have a role in myeloid neoplasms. 
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Figure legends 
Figure 1. Vav-Atmin∆/∆ LT-HSCs have impaired functions during 
regeneration and aging. Experiments were performed with young (A-F) and 
aged (H-N) BM cells. Black bars/symbols represent Atminf/f and white Vav-
Atmin∆/∆ unless otherwise indicated. (A, H) Total cellularity and absolute 
numbers of the indicated sub-populations were determined in the BM of 
Atminf/f and Vav-Atmin∆/∆ mice (from two tibiae, two femurs and two iliac 
crests; n=5-6/genotype). (B, I) Frequencies of the different primitive BM 
stem/progenitor sub-populations (n=6-8/genotype) were also analyzed. 
Horizontal bars indicate the mean. (C, J) Cell cycle distribution was 
determined using Ki67/DAPI stains in the indicated BM stem/progenitor sub-
populations (n=4/genotype). (D) To evaluate the regeneration capacity of LT-
HSCs, peripheral blood (PB) chimerism was determined at different time 
points from sub-lethally irradiated NSG mice (non-obese diabetic/severe 
combined immunodeficiency disease/interleukin-2 receptor γ-chain–null; 
CD45.1 due to the mixed background) that were transplanted with 15 young 
LT-HSCs from either Atminf/f or Vav-Atmin∆/∆ mice (CD45.2). After 16 wks, 15 
LT-HSCs were sorted by flow cytometry from primary mice and re-
transplanted into separate secondary recipients and PB chimerism was 
determined at different time points. (K) PB chimerism was also determined 
from sub-lethally irradiated NSG mice transplanted with 15 aged LT-HSCs 
from either Atminf/f or Vav-Atmin∆/∆ mice. Each symbol indicates a mouse and 
horizontal lines represent median reconstitution levels. (E, L) As Atm-/- LT-
HSCs have 10-fold elevated ROS compared to WT cells10, we investigated 
ROS production in Atminf/f or Vav-Atmin∆/∆ LT-HSCs. DCFDA stains for ROS 
detection are shown. Values indicate the percentage of ROS-positive cells 
(n=3/genotype). (F, M) qRT-PCR for the expression of the indicated DNA 
oxidation repair genes in LT-HSCs was also evaluated. Expression values 
were relative to the mean of each control sub-population (n=3/genotype). (G, 
N) pKap1 expression in LT-HSCs was determined by intracellular flow 
cytometry analysis. Grey and open histograms represent isotype-matched 
control and pKap1 stains respectively. Unless stated, mean (SD) values are 
shown. *, P<0.05; **, P<0.005; ***, P<0.0005. The different BM hematopoietic 
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stem and progenitor populations were defined as follows: LT-HSC ((L-S+K+ 
(Lineage-Sca-1+cKit+) CD34-/loFlt3-); ST-HSC (L-S+K+ CD34+Flt3-); MPP (L-
S+K+CD34+Flt3+); CMP (L-S-K+IL7R-CD34+FcγR−); GMP (granulocyte-
monocyte progenitor, L-S-K+IL7R-CD34+FcγR+); MEP (megakaryocytic-
erythroid progenitor;	  L-S-K+IL7R-CD34-FcγR-); CLP (L-S-KloIL7R+). 
 
Figure 2. ATMIN-deficient mice have a reduced CMP compartment due to 
increased apoptosis. Black bars/symbols represent Atminf/f and white Vav-
Atmin∆/∆ unless otherwise indicated. (A) DCFDA stains for ROS detection 
showing a mild increase in the percentage of ROS-positive cells in ATMIN-
deficient CMPs (n=3/genotype). (B) Treating total BM cells with the 
antioxidants NAC or γ-GCE (not shown) was unable to rescue the myeloid 
colony formation (CFU) defect of Vav-Atmin∆/∆ cells (n=5/genotype). (C) 
Expression of key anti-oxidant genes was unchanged between ATMIN-
deficient and control CMPs. Expression values were determined by qRT-PCR 
and were relative to the mean (n=3-5/genotype). No significant increase in 
pKap1 levels (indicative of ATM activation) (D), upregulation of genes in the 
DNA oxidation repair pathway (E), or changes in the indicated CMP 
developmental factors (F) were detected in ATMIN-deficient compared to 
control CMPs. pKap1 levels were determined by intracellular flow cytometry 
analysis (MFI ratios are shown) and qRT-PCR was used to determine the 
expression of the indicated genes (n=5-6/genotype). (G) The frequency of late 
apoptosis was significantly increased and (H) Dynll1 expression was 
drastically reduced in CMPs lacking ATMIN compared with control cells (n=4-
6/genotype). (I) Representative cell images captured by an ImageStream flow 
cytometer in brightfield, followed by their respective composite images, 
showing higher co-localization of mitochondria (red) with Bim (green) staining 
in Vav-Atmin∆/∆ CMPs. (J) Representative MitoTrackerRed-CMXRox and Bim 
similarity staining score histograms for Atminf/f (black) and Vav-Atmin∆/∆ 
(open)-derived CMPs respectively. A score above value 2 (R1) indicates 
translocation of Bim into mitochondria. (K) Percentage of Bim translocation in 
CMPs (n=3/genotype). Mean (SD) values are shown. P<0.05; ***, P<0.0005. 
 


 Supplementary Figures 
 
Figure S1. ATMIN-deficient mice are leukopenic. (A) Genotyping of Atmin 
WT, floxed and Δ alleles by PCR from tail, thymus, spleen and bone marrow 
(BM) of Atminf/f, Atminf/+ and Vav-Atmin∆/∆ mice. (B) Representative western 
blot using Atminf/f and Vav-Atmin∆/∆ bone marrow lysates. Adult Vav-Atmin∆/∆ 
mice are leukopenic but not anemic as shown by (C) the reduced absolute 
peripheral blood leukocyte (CD45+), B cell, T cell, granulocyte and (D) red 
blood cell counts respectively (n=6/genotype; 8-12-wks old). Mean (SD) 
values are shown. *, P<0.05; ***, P<0.0005. 
 
Figure S2. ATMIN-deficient mice have B cell lymphopenia. (A) Analysis of 
total B cell (B220+) numbers in the spleens of Vav-Atmin∆/∆ mice and Atminf/f 
litter-mates (8-12-wk-old; n=5/genotype) showing a ~75% reduction in total B 
cell numbers in Vav-Atmin∆/∆ mice compared with control mice. This was 
accompanied by a significant reduction in (B) the frequency of immature and 
re-circulating B cells (n=5/genotype) and (C) loss of germinal centre (GC) and 
red pulp regions (RP; representative H&E stainings of spleens are shown). 
(D) No increase in intracellular reactive oxygen species (ROS) was detected 
in the different Vav-Atmin∆/∆ B cell sub-populations (n=3/genotype). (E) A 
significant 2-fold increase in early apoptosis was observed in all the different 
B cell sub-sets analyzed (each dot represents a mouse), likely caused by a 
Bim-dependent apoptotic mechanism12 as a result of reduced Dynll1 
expression (a direct ATMIN transcriptional target9) detected in Vav-Atmin∆/∆ 
cells (F). Expression values were determined by qRT-PCR and were relative 
to the mean of each control population (n=3-5/genotype). (G, H) Atmin-
deleted B cells show an increase in pKap1 (an ATM substrate) and γH2AX 
compared with control B cells, indicating a higher DNA damage response in 
the absence of ATMIN. Expressions were determined by intracellular flow 
cytometry analysis and mean fluorescence intensity (MFI) ratios are shown. 
(I) Total B cell numbers are significantly reduced in the BM of Vav-Atmin∆/∆ 
mice compared with Atminf/f littermates (from two tibiae, two femurs and two 
iliac crests; n=6-7/genotype). Pre-B cell counts are reduced by 50%. (J) No 
accumulation of other primitive B cell sub-sets was observed in the absence 
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of ATMIN. (K) BM cells were unable to efficiently generate pre-B cell colonies 
in vitro (n=3/genotype; in triplicate each). Mean (SD) values are shown. *, 
P<0.05; **, P<0.005; ***, P<0.0005. 
 
Figure S3. Defective regeneration capacity of Vav-Atmin∆/∆ LT-HSCs after 
5-FU treatment. (A) qRT-PCR for the expression of Cdkn1c and Rbl2 in the 
indicated BM sub-populations. Expression values are relative to the mean of 
each control sub-population (n=3-5/genotype). Other cell cycle regulators 
were unchanged between ATMIN-deficient and control cells (data not shown). 
(B) Contribution of the transplanted primary LT-HSCs (as shown in Figure 1D) 
to the B, T and granulocyte cell lineages. Each symbol indicates a mouse and 
horizontal lines represent median reconstitution levels. (C) Frequency of late 
apoptosis in young LT-HSCs (n=4-6/genotype). (D) Kaplan-Meier survival 
curve of Atminf/f and Vav-Atmin∆/∆ mice injected 3 times (arrows) with 5-FU 
(n=6-8/genotype). Mean (SD) values are shown. *, P<0.05; **, P<0.005. 
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Supplementary Materials and Methods 
Mice 
NSG mice: Nonobese diabetic/severe combined immunodeficiency 
disease/interleukin-2 receptor γ-chain–null (NOD/SCID IL2Rγnull; NSG) mice 
were originally obtained from Dr Leonard Schultz (Jackson Laboratory) and 
bred in the London Research Institute Biological Resources Unit. Mice were 
kept in micro-isolators and fed sterile food and acidified water. All 
experimental procedures were approved by London Research Institute ethics 
committees and conform to the UK Home Office regulations. 
 
Bone marrow transplantation and 5-FU treatment 
 NSG mice aged 8 to 12 weeks were irradiated at 3.75 Gy (137Cs 
source) up to 24 hours before tail vein injection of flow cytometry-purified 
primary cell populations. For secondary transplants, two NSG mice that 
received LT-HSCs from either Atminf/f or Vav-Atmin∆/∆ mice were randomly 
pooled and sorted again for LT-HSCs and injected into two sub-lethally 
irradiated NSG mice. Eight-twelve week-old Atminf/f and Vav-Atmin∆/∆ mice 
received 3-times injection of 5-FU (150 mg/Kg body weight) and were 
analyzed for different white blood cell counts and survival respectively. 
 
Hematopoietic analyses 
 Single-cell suspensions were first obtained from different hematopoietic 
tissues, then red blood cells were lysed and samples stained for 30 min. at 
4°C with the indicated antibodies in PBS supplemented with 2% FCS 
(PBS/2%). DAPI was added to exclude dead cells in the flow cytometry 
analysis. For complete blood counts, peripheral blood was collected from the 
tail vein into tubes containing K2EDTA. Twenty-five µl of blood was stained for 
different leukocyte antigens as described then without washing diluted to 1 ml 
and analysed in a MACSQuant analyser (Miltenyi Biotec). For red blood cell 
counts, blood was diluted 1:1000 and red cells were counted in a 
hemocytometer. The following antibodies (from BD Bioscience and 
eBioscience) were used: Lineage cocktail, CD45.1 (A20), CD45.2 (104), B220 
(RA3-6B2), Ly-6G (Gr1; RB6-8C5), CD3 (17A2), Sca-1 (D7), CD117 (c-Kit; 
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2B8), CD34 (RAM34), CD16/32 (93), CD43 (S7), IgM (II/41), CD135 (Flt3; 
A2F10), CD127 (IL7Rα; A7R34) and AnnexinV. 
 
Analysis of intracellular ROS and mitochondria.  
 Cells were incubated with the ROS detection agent DCFDA (carboxy-
H2DFFDA C13293; Life Technologies) at 5 µM or MitoTrackerRed-CMXRos 
(M7512; Life Technologies) at 12.5 nM and incubated at 37°C for 30 min. 
After this period cells were washed with PBS/2% FBS containing trypan blue 
to quench nonspecific staining. 
 
Gene Expression Analysis 
 RNA was extracted using the RNeasy Micro Kit (Qiagen, Inc.) and 
treated with DNase.  Reverse transcription was performed using the 
SensiScript Kit (Qiagen) according to the manufacturer's instructions. For 
quantitative real-time polymerase chain reaction (qRT-PCR), SybrGreen 
master mix reagent (Applied BioSystems) was used and the amplification was 
done using the ABI Prism 7700 sequence detection system (Applied 
BioSystems). To avoid possible amplification of contaminating DNA and 
unprocessed mRNA, where possible, primers were designed to anneal the 
end parts of two exons. The specificity of the PCR products was verified by 
running a 2% agarose gel, in addition to using the dissociation curve software 
from the qRT-PCR system.  Primers used are listed in Table S1. 
 
Colony assays 
 Standard methylcellulose colony assay media, MethoCult® GF M3534 
was used according to the manufacturer’s instructions. NAC (N-acetyl 
cysteine; Sigma) or γ-GCE (glutathione monoethyl ester; Calbiochem) was 
added to the methylcellulose at 100 µM or 2 mM respectively when cells were 
seeded and then at day 5. Colonies were scored at day 10.  
 
Immunohistochemistry and immunocytochemistry 
 Tissue was fixed overnight in 10% neutral buffered formalin, briefly 
washed with PBS and transferred into 70% ethanol, processed and 
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embedded into paraffin. Sections were cut at 4 µm for H&E staining and 
immunohistochemistry using an antibody against B220 (BD Biosciences) and 
pS139-γH2AX (Abcam). For cell suspensions cells were allowed to attach to 
poly-L-lysine coated slides for 15 min. Flow cytometry-purified sub-
populations were sorted directly onto poly-L-lysine-coated slides containing 
PBS/2% FBS before fixation. All cells were fixed with 4% paraformaldehyde at 
RT for 10 min, permeabilized with PBS/0.1% TX for 10 min, blocked with 10% 
serum (donkey or goat) for 30 min at RT, incubated with primary antibodies at 
4°C overnight and then with appropriate secondary antibodies for 1 hour at 
RT. Slides were mounted with Fluorescence Mounting Medium (Dako) 
containing DAPI for nuclear staining.   
 
Western blotting  
 Cells were extracted in RIPA lysis buffer (NEB) supplemented with 
protease inhibitors (Sigma). Western blots were performed using standard 
procedures. Protein samples were separated by SDS–PAGE, and 
subsequently transferred onto nitrocellulose membranes. All primary 
antibodies were used at 1:1000 dilution and secondary antibodies at 1:2000. 
The following antibodies were used: p-S824-Kap1 (Bethyl Laboratories, Inc); 
ATMIN, (Millipore); β-actin (Sigma); α−tubulin (Abcam); HRP-conjugated goat 
anti-mouse/rabbit IgG (Sigma). 
 
ImageStream analysis  
 Cells were stained first for extracellular antigens followed by 
mitochondria staining. Cells were then fixed, permeabilized and stained for 
Bim as described above. Samples were analyzed on an ASSIST calibrated 
Dual Camera, 12 Channel ImagestreamX Mark II Imaging Flow Cytometer 
(Amnis, Merck Millipore) using INSPIRE software (Amnis, Merck 
Millipore). Images were collected using a 60x objective lens and sample data 
were acquired on a low speed and high sensitivity setting. Fluorescence was 
measured from 405nm, 488nm and 642nm lasers. Laser powers were set to 
30mW, 50mW and 30mW respectively. A dot-plot of area vs aspect ratio for 
Brightfield Ch01 was gated to exclude debris during data acquisition. Single 
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stained cells were measured and a compensation matrix created; the 
acquired data were compensated and analysed using IDEAS software 
(Amnis, Merck Millipore). Gates were set to include single, focused cells and 
then gated for cells which were dual stained with MitoTrackerRed-CMXRos 
(Ch04) and Bim AlexaFluor 488 (Ch02). The “similarity” feature was used to 
assess the colocalization of the MitotrackerRed-CMXRos and Bim on selected 
cell populations. The following modified feature and mask was used to 
measure and define the region where the colocalization of the 2 dyes occurs: 
Similarity Threshold: Similarity Threshold ((Object (M04, Ch04 MitoCMXRos, 
Tight), Ch04 MitoCMXRos: 60))_Ch02 Bim AF488_Ch04 MitoCMXRos. Cells 
which scored more than 2 on this feature were assessed to have high 
Bim/mitochondria colocalization.  
 
Statistical analysis 
 T-tests were used for most analyses. Statistical analysis of the 
engraftment data was performed using the Mann-Whitney test. The P value 
for the Kaplan-Meier survival curve was calculated using the Mantel-Cox test. 
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Table S1. List of primers used in this study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 



